Does LEVOMILNACIPRAN Cause Facet joint syndrome? 136 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Facet joint syndrome have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 9.9% of all adverse event reports for LEVOMILNACIPRAN.
136
Reports of Facet joint syndrome with LEVOMILNACIPRAN
9.9%
of all LEVOMILNACIPRAN reports
136
Deaths
90
Hospitalizations
How Dangerous Is Facet joint syndrome From LEVOMILNACIPRAN?
Of the 136 reports, 136 (100.0%) resulted in death, 90 (66.2%) required hospitalization, and 91 (66.9%) were considered life-threatening.
Is Facet joint syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Facet joint syndrome?
RITUXIMAB (1,497)
METHOTREXATE (1,483)
TOCILIZUMAB (1,467)
LEFLUNOMIDE (1,464)
DICLOFENAC (1,441)
ALENDRONATE (1,425)
SECUKINUMAB (1,420)
ABATACEPT (1,410)
ADALIMUMAB (1,377)
FOLIC ACID (1,346)
Which LEVOMILNACIPRAN Alternatives Have Lower Facet joint syndrome Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE